obesity-995x60.png
FEATURED ARTICLES
Brazil's Regulatory Transformation: A New Era For Clinical Development
Brazil’s clinical research transformation takes center stage as this new Q&A series opens with Interfarma CEO and former ANVISA director Renato Porto.
-
What Can Healthy Participants Tell Us In Early Immuno-oncology Development?
Healthy participants may help answer early immuno-oncology questions when targets, endpoints, and risks align. Human data shows where this approach works and where it doesn’t.
-
The Scout Effect: Helping Keep Clinical Trials On Track
Experience the stability that comes when patients, sites, and sponsors each get the support they need to keep moving without interruption.
-
Can Reimbursement Assumptions Create Participant Burden In Clinical Trials?
Reimbursement policies often rest on assumptions about travel, timing, and participant costs. Learn how those assumptions can create a burden on participants and what you should test before enrollment.